Paradigm Capital Management Inc Eton Pharmaceuticals, Inc. Transaction History
Paradigm Capital Management Inc
- $2.07 Billion
- Q1 2024
A detailed history of Paradigm Capital Management Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Paradigm Capital Management Inc holds 300,000 shares of ETON stock, worth $1.05 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
300,000
Previous 300,000
-0.0%
Holding current value
$1.05 Million
Previous $1.31 Million
14.38%
% of portfolio
0.05%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding ETON
# of Institutions
45Shares Held
7.13MCall Options Held
52.7KPut Options Held
0-
Opaleye Management Inc. Boston, MA2.45MShares$8.56 Million2.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$3.6 Million0.0% of portfolio
-
Westside Investment Management, Inc.585KShares$2.05 Million0.44% of portfolio
-
Acuitas Investments, LLC580KShares$2.03 Million1.15% of portfolio
-
Black Rock Inc. New York, NY283KShares$990,3320.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $88.5M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...